SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-22-000927
Filing Date
2022-07-27
Accepted
2022-07-27 16:16:55
Documents
13
Period of Report
2022-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52793689.htm   iXBRL 8-K 29021
2 EXHIBIT 99.1 a52793689ex99_1.htm EX-99.1 5436
  Complete submission text file 0001157523-22-000927.txt   173612

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA usna-20220725.xsd EX-101.SCH 3914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20220725_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20220725_pre.xml EX-101.PRE 16036
7 EXTRACTED XBRL INSTANCE DOCUMENT a52793689_htm.xml XML 4080
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 221111215
SIC: 2833 Medicinal Chemicals & Botanical Products